VOR - Vor Biopharma Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
31.84 -1.07 (-3.36%) --- --- 0.0 (0.0%) 1.16 (3.64%) -2.71 (-8.23%) 0.45 (1.49%) 0.45 (1.49%)

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
-12.56
Diluted EPS:
-12.56
Basic P/E:
-2.4498
Diluted P/E:
-2.4498
RSI(14) 1m:
0.0
VWAP:
30.77
RVol:

Events

Period Kind Movement Occurred At

Related News